Trending News
News
News
Capsugel and Pulmatrix Enter Collaboration to Develop and Manufacture Novel Inhaled Therapeutics
Company has announced the collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases.
News
Leading CDMO is Granted Both the Worldstar Award for Vetter-Ject® and a 2016 CMO Leadership Award
Company has announced that the worldStar competition is one of the major events of the WPO, and its award represents the pre-eminent international award in packaging.
News
Optimum Results With the New Metal Scavenger Screening Kit From Biotage
Company has announced the launch of their new Metal Scavenger Screening Kit for the pharmaceutical, drug discovery process and fine chemical industries.
News
Vaccine Against Dangerous Designer Opioids
With use of synthetic opioid "designer drugs" on the rise, scientists from The Scripps Research Institute (TSRI) have a new strategy to curb addiction and even prevent fatal overdoses.
News
Big Data and Analytics Can Tame Rising Cost of Chemical R&D
Novel sensors, cheminformatics, and advanced analytics can help bring new products to market faster and cheaper in the chemical industry, according to Lux Research.
News
CPhI Worldwide Introduce New Event
Expanding its reputation as a global hub for the final dose supply chain is a key strategy for CPhI in 2016.
News
TAxI Shuttles Protein Cargo into Spinal Cord
A small peptide, TAxI, holds hope for administering treatments for motor neuron disorders via a muscle injection.
News
"Beiging" White Fat Cells to Fight Diabetes
Penn Study reveals a signaling pathway required for beige fat formation.
News
AbbVie Joins Dementia Consortium
The Dementia Consortium has welcomed AbbVie as new pharmaceutical partner, joining medical research charity MRC Technology, Alzheimer’s Research UK, the UK’s leading dementia research charity, and pharmaceutical companies Astex, Eisai and Lilly.
News
Galapagos Starts Saphira Phase 2 Study With Glpg1837 In Cystic Fibrosis Patients
Company has announced its Phase 2 exploratory program of GLPG1837 in patients with cystic fibrosis.
Advertisement